A Randomized Placebo-Controlled Double-Blind Clinical Trial to Assess the Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 20 May 2016
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 01 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Oct 2009 New trial record